ALX Oncology Inc. (ALXO) Balance Sheet Analysis - Assets, Liabilities & Financial Position - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    ALX Oncology Inc.

    NASDAQ: ALXO · Real-Time Price · USD
    2.18
    0.27 (14.14%)
    At close: Oct 03, 2025, 3:59 PM
    2.15
    -1.38%
    After-hours: Oct 03, 2025, 07:51 PM EDT

    ALX Oncology Balance Sheet Statement

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
    Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
    Cash & Equivalents
    		 17.57M 22.41M 48.82M 363.67M
    Short-Term Investments
    		 110.19M 160.33M 217.38M n/a
    Long-Term Investments
    		 3.52M 35.41M 16.7M n/a
    Other Long-Term Assets
    		 267K 7.64M 9.01M 9.69M
    Receivables
    		 892K 1M 1M n/a
    Inventory
    		 n/a n/a -17.7M n/a
    Other Current Assets
    		 5.7M 4.92M 16.7M n/a
    Total Current Assets
    		 134.35M 188.66M 270.97M 367.02M
    Property-Plant & Equipment
    		 9.63M 10.84M 9.81M 3.47M
    Goodwill & Intangibles
    		 n/a n/a n/a n/a
    Total Long-Term Assets
    		 13.42M 53.89M 35.52M 13.16M
    Total Assets
    		 147.78M 242.55M 306.49M 380.18M
    Account Payables
    		 4.5M 8.59M 8.07M 3.76M
    Deferred Revenue
    		 n/a n/a n/a n/a
    Short-Term Debt
    		 435K 1.57M 1.04M 742K
    Other Current Liabilities
    		 7.88M 17.65M 14.46M 444K
    Total Current Liabilities
    		 18.5M 36M 28.32M 15.29M
    Long-Term Debt
    		 9.47M 9.64M 9.39M n/a
    Other Long-Term Liabilities
    		 1.03M 1.22M 5.31M 1.84M
    Total Long-Term Liabilities
    		 15.66M 16.84M 14.7M 1.84M
    Total Liabilities
    		 34.16M 52.84M 43.02M 17.13M
    Total Debt
    		 9.9M 17.2M 10.43M 742K
    Book Value
    		 113.62M 189.71M 263.46M 363.05M
    Book Value Per Share
    		 2.18 4.41 6.47 9.01
    Common Stock
    		 53K 50K 41K 41K
    Retained Earnings
    		 -621.12M -486.27M -325.47M -201.99M
    Comprehensive Income
    		 275K 256K -845K n/a
    Shareholders Equity
    		 113.62M 189.71M 263.46M 363.05M
    Total Investments
    		 113.71M 195.74M 234.08M n/a

    Add to Watchlist